CRMD
NASDAQ · Pharmaceuticals
Cormedix Inc
$7.92
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+562.9% upside
Low Target
$41.99
Average Target
$52.50
High Target
$66.46
Current Price
$7.92
Current
$7.92
$7.92
Target
$52.50
$52.50
$41.99
$52.50 avg
$66.46
Scenario Analysis
Bear Case
$41.99
430.2%
Low target
Base Case
$52.50
+562.9%
Avg target
Bull Case
$66.46
+739.1%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$17.43
-54.6% from high
52-Week Low
$6.13
+29.2% from low
Target vs 52W High
$52.50
+201.2% vs high
Next Earnings Report
May 14, 2026 · Before Market Open
2d
until earnings
EPS Est: $0.37
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals